Xoma reveals successful exchange offer

13 February 2006

Xoma of the USA has announced that $60.0 million in aggregate principal amount of its 6.50% convertible senior notes due 2012, or 100% of the total outstanding, were tendered and not withdrawn in its previously-announced exchange offer which expired at midnight, New York City time, on February 8. As a result, the the firm will issue $60.0 million in aggregate principal amount of 6.50% convertible SNAPssm due 2012.

The company also says the placement of $12.0 million in aggregate principal amount of additional convertible SNAPssm to the public for cash. Due to investor demand, the size of the offering was increased from $10.0 million and the public offering price was set at 104% of principal. Both the exchange offer and the placement of new notes are expected to close on February 10.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight